BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://www.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T170000
DTEND;TZID=Europe/London:20201005T180000
DTSTAMP:20260403T195312
CREATED:20200403T084137Z
LAST-MODIFIED:20200403T084137Z
UID:18136-1601917200-1601920800@www.medilinkmidlands.com
SUMMARY:Medilink Midlands Virtual Autumn Networking
DESCRIPTION:  \n  \n  \n  \n  \nJoin Medilink Midlands for our virtual Autumn Networking event\, in association with the City of Mentor\, USA. \nNetworking opportunities are one of the many Medilink Midlands member benefits and as the current COVID-19 restricts the opportunity for face to face events\, our Autumn Networking event will now be virtual. \nThis is an informal gathering and will provide an opportunity for both members and non-members to engage with one another as well as their US counterparts. \nBecause of our growing relationship with the City of Mentor\, Ohio\, we have moved our autumn networking to the 5th October\, and it will now be incorporated within the B2B International Networking  at the annual trade mission made by the City of Mentor. The networking will take place towards the end of the conference. As well as the B2B International Networking \, they are hosting an afternoon’s conference. This will provide a chance to learn more about the advantages of doing business in Northeast Ohio and the City of Mentor . \nTo book your place and for further details please click here.\nOpen to both Medilink members and non-members. There is no charge for attending this event. \nPlease note: When booking\, you will be registered for the whole conference\, however you have the option to join at any time\, including just the B2B International Networking opportunity. \nBookings are being managed by The City of Mentor International Trade Initiative\, via Eventbrite. Delegates will receive login credentials and instructions in the week prior to 5 October.
URL:https://www.medilinkmidlands.com/event/autumn-networking/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/potter-clarkson-hires-rgb-logo-colour-scaled.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T133000
DTEND;TZID=Europe/London:20201006T210000
DTSTAMP:20260403T195312
CREATED:20200907T114109Z
LAST-MODIFIED:20200907T114109Z
UID:18365-1601904600-1602018000@www.medilinkmidlands.com
SUMMARY:Mentor Means Business - Conference and Networking
DESCRIPTION:  \n  \n  \n  \n  \n  \nThe Northeast Ohio region is home to some of the leading medical institutions in the United States\, including the Cleveland Clinic\, and the region has developed one of the nation’s most important biomedical clusters. \nOver 700 biomedical firms are located there\, including over 400 medical device manufacturers specializing in imaging\, neuro-stimulation\, orthopaedics\, cardiovascular\, and sterilization.  Among these are world leaders such as General Electric Healthcare\, Siemens\, Toshiba\, Hitachi\, Philips Healthcare\, and STERIS.  STERIS Corporation was founded in Mentor in 1985. Today\, STERIS is a global leader in infection prevention\, contamination control\, surgical and critical care technologies\, and more.  Other top Mentor biomedical companies include Volk Optical\, Frantz Medical Group\, SourceOne Merry X-Ray Corporation\, and Integrated Medical Solutions. \nInternationally recognized clinical research institutions\, including the prestigious Cleveland Clinic\, University Hospitals\, and Case Western Reserve University\, provide Mentor biomedical and med-tech companies a world-class platform for research\, design\, and innovation. \nOhio’s commitment to supporting investment in the biotech industry and these centres of excellence and innovation have driven Ohio’s biomedical industry to grow by 59% since the year 2000\, now employing over 80\,000 experienced workers. \nMentor\, Ohio is strategically located in the heart of this cluster and ready to assist international biomedical and MedTech companies to invest for success. \nOn 5 October 2020\, we are pleased to offer you the opportunity to learn more about the advantages of doing business in Northeast Ohio and the City of Mentor by participating in a virtual conference focused on Ohio’s Medtech innovation corridor. \nConference activities include: \n\nDiscussion with experienced legal advisors on setting up your US business operations and positioning your company for success in the North American market.\nGuidance from high-level US hospital system personnel on the particulars of getting your products and services into the US healthcare system.\nDirect interaction and potential dialogue with US companies and officials that can help you bring your products and services into the United States.\nA company panel talk on doing business in MedTech and BioMed in the US\, featuring TWO Medilink EM Members\, Uvamed and eg Technology.\nMedilink Autumn Networking will be incorporated into the B2B International Networking towards the end of the Conference\, providing an opportunity for both members and non-members to engage with their US counterparts.\n\nFor more information\, contact the Department of Planning and Development at business@cityofmentor.com or visit www.mentormeansbusiness.com. \nTo register for the conference\, click here\nCONFERENCE AGENDA \n8:30 AM EDT / 13.30 BST / 14.30 EST\nWelcome and Presentation\nNortheast Ohio and the City of Mentor – Discovering the competitive advantage for international companies\, particularly in the biomedical and medtech sector\, impacts of COVID-19. \n9:15 AM EDT / 14.15 BST / 15.15 EST\nPresentation\nSetting up your US business operation – things to keep in mind\, effective strategies\, and pitfalls to consider\n     Howard Goulden\, Howard Kennedy\nSteven Howard Roth\, Associate\, Roetzel and Andress \n10:00 AM EDT / 15.00 BST / 16.00 EST      \nBrief Break \n10:10 AM EDT / 15.10 BST / 16.1- EST\nPresentation\nThe Healthcare/BioTech/MedTech Ecosystem in the US/State of Ohio\n       Tyler Allchin\, Director\, Healthcare\, JobsOhio  \n10:35AM EDT / 15.15 BST / 16.15 EST       \nPresentations\nAccessing the business operations of US medical centres\, strategies for success.\n     David Sylvan\, President\, UH Ventures\, University Hospitals\nCleveland Clinic Personnel \n11:15AM EDT / 16.00 BST / 17.00 EST       \nPanel Discussion\nDoing business in biomedical/medtech in the United States\, particularly in a COVID and post-COVID environment\n       Steve Norton\, STERIS Corporation\nJustin Bloyd\, RB Sigma\nKeith Fawdington and Jon Snyder\, UVAMED/Rainbow Trays\nDr. Rouzet Agaiby\, EG Technology \n11:45AM EDT / 16.45 BST / 17.45 EST       \nPresentation\nCleveland Clinic UK Operations from London\n     Travis Laird\, Chief Business Operations Officer \n12:00PM EDT/17.00 BST/18.00 EST\nVirtual B2B Networking\nOpportunity to talk real-time with biomedical and medtech companies from both sides of the Atlantic. \n12:30PM EDT / 17.30 BST / 18.30 EST\nConclusion\nClosing remarks \nTuesday\, 6 October \n9:00AM EDT / 2:00PM BST / 3:00PM EST \nCleveland Clinic Innovation Summit 2020 – Virtual \nTo register for the Cleveland Clinic Summit go to:  https://innovations.clevelandclinic.org/Summit/Overview.aspx
URL:https://www.medilinkmidlands.com/event/mentor-means-business/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/City-of-Mentor-Seal-1.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201005T080000
DTEND;TZID=Europe/London:20201005T170000
DTSTAMP:20260403T195312
CREATED:20201005T104654Z
LAST-MODIFIED:20201005T104654Z
UID:18383-1601884800-1601917200@www.medilinkmidlands.com
SUMMARY:SEHTA & eg Technology Series of Medical Devices Product Design & Development Webinars November 2020
DESCRIPTION:SEHTA and eg Technology are delighted to be running a second series of Medical Devices Product Design & Development Webinars to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 45 mins max at 14:00 – 14:45 (BST) \nThese webinars will be run via WEBEX – details on application \nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \n£50 +VAT pp per webinar for SEHTA Members \n£60 +VAT pp per webinar for Non-members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nBelow is a list of all available webinars with dates – you can choose as many webinars as you wish to take part in. \n\n\n\nWebinar\nSession Title\nDate\n\n\n1\nNew Product Development – First things First \n  \nWhether you are a first-time entrepreneur or part of a large medical company\, starting a new product development programme can feel like a daunting task. So where should you start? What things do you need to consider at the outset to turn your idea into reality? Starting with an overview of the product development process\, this webinar will move onto the most important\, and often the most overlooked aspect of product development – understanding the user. \n  \nTopics to be covered include: \n  \n·         The key things to consider from the outset of any development programme \n·         The importance of putting the user first \n·         How to obtain useful user insights \n·         How to leverage those insights to make a better product \n \nTuesday 10th November 2020\n\n\n\nFacilitator\nDanny Godfrey\, Co-Founder\, eg Technology \nIn 2002\, Danny and Andrew founded eg technology ltd\, a product design engineering company based in Cambridge UK. They have grown the company organically since then\, and now employ over 30 engineering and commercial staff. \nDanny’s role is to provide corporate leadership\, develop new business opportunities and oversee the technical and strategic direction of projects. He remains involved with the work that eg does\, from the initial proposal writing\, technical & creative input\, design implementation\, review processes and the early identification of development risks. Motivating staff and nurturing client relationships are important aspects of Danny’s day-to-day work – valuing and developing our team of bright\, can-do people and ensuring clients are satisfied with what eg does have been the foundations of success for the company. \nDanny is also a member of the MedTech Accelerator Awards Committee. This organisation supports and finances projects for early-stage companies in the medical sector to create future spin-out companies that aim to bring new life-enhancing technologies to market. \n \n\n\nWebinar\nSession Title\nDate\n\n\n2\nDefining User and Product Specifications During Product Development \n  \nThis webinar will cover what User Requirement Specification (URS) and Product Requirement Specification (PRS) are\, how they differ and how to define them during the product development process. The webinar will end with an interactive quiz. \n  \nTopics to be covered include: \n  \n·         What is a URS and PRS and how do they differ? \n·         What do the standards ask for? \n·         Where do the URS and PRS sit in the product design and development process? \n·         Writing the URS and PRS – best practices \n·         Things to watch out for \n·         Interactive quiz \n \nTuesday 17th November 2020\n\n\nFacilitator\nKella Kapnisi\, Project Manager\, eg Technology \nKella works as part of the project management team. She is responsible for delivering projects from concept through to production\, on time and within budget. Working closely with clients to ensure successful projects across a wide range of products\, including medical devices\, IVDs\, lab equipment & consumer products.  \n  \nKella is also involved in strategic reviews of project operations\, to ensure efficiency in our internal engineering design processes. She led the implementation of the requirement specification process at eg technology\, which forms part of our Quality Management System and she delivered the resultant company-wide training sessions. \n  \nKella has a background in polymer chemistry and a PhD in biomaterial engineering\, under Prof Molly Stevens at Imperial College London\, where she developed tissue engineered cardiac patches for treating heart attacks. Prior to joining eg technology\, Kella was part of a start-up developing implantable heart assist pumps. \n \n\n\n\nWebinar\nSession Title\nDate\n\n\n\n3\nSoftware Design for Medical Devices \n  \nThis webinar will cover Software Design for Medical Devices\, starting with a quick overview to medical device classification\, international standards and the role of IEC 62304. This webinar is intended to look in more detail at some practical applications of the software development processes and what it actually means for the engineers \n  \nTopics to be covered include: \n  \n·         Medical Device Classification & IEC 62304 – a quick refresher \n·         What makes software development different? \no    Software Development \no    Software Testing \no    Software Updates \n·         Structuring software development in practise \no    How to limit the scope of large software projects? \no    Where to draw a boundary around the software components? \no    How to maintain flexibility to update without major retesting/resubmission \no    Software decomposition of safety critical items \n·         Software maintenance considerations \no    What are the regulators worried about? \no    When is a bug not a bug? \n \nTuesday 24th November 2020\n\n\n\nFacilitator\nDavid Warwick\, Director\, eg Technology \nDavid joined eg in 2009 and was appointed as a Director of the company in 2019. As a Director\, he has an overall responsibility for bringing in new business to eg technology and works with the senior management team to constantly evaluate how the business operates to ensure that the company’s strategies support the future growth of eg.  \n  \nDavid’s technical background is in Software Engineering and Electronic Design with over 15 years’ experience in developing medical and IVD device software. During his time at eg technology he has helped numerous clients with the compilation of their technical files and the CE marking and FDA approval of medical devices and IVDs as well as outsourcing final product manufacture. His experience with software development includes extensive experience working with IEC 62304 across all software safety classifications. \n \n\n\n\n For more information on each webinar and to register please click below \n Click Here
URL:https://www.medilinkmidlands.com/event/sehta-eg-technology-series-of-medical-devices-product-design-development-webinars-november-2020/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T113000
DTSTAMP:20260403T195312
CREATED:20200327T100140Z
LAST-MODIFIED:20200327T100140Z
UID:18108-1601546400-1601551800@www.medilinkmidlands.com
SUMMARY:Webinar: Commercial Applications for Next Generation Biomaterials
DESCRIPTION:This webinar with the University of Nottingham will look at Commercial Applications for Next Generation Biomaterials. \nThe biomaterials discovery programme at the University of Nottingham has been targeting novel polymers with application as coatings for existing medical devices to reduce infection rates and controlling foreign body reaction\, cell culture consumables for expansion and differentiation of stem cells\, particulates for targeting therapeutic delivery for cancer and infections and surfaces to control viral\, fungal and bacterial attachment in a wide variety of industries. They are looking for industrial organisations to partner with in the exploitation of these materials. \nPresentations will include: \n– Controlling bacterial biofilms formation using polymers \n– Controlling foreign body reaction to medical implants using coatings \n– New materials for breast cancer therapies \n– Technologies to control Fibrosis \nThere will be a Q&A session during the webinar. We have also created a facility post event (11.30am – 12.00pm) for you to join the presenters in a Microsoft Teams meeting to ask further questions directly to the presenters. Details of this meeting will be shared during the webinar. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nThe Biomaterials Discovery project at the University of Nottingham has funding available to partner with industrial partners that are keen to explore its emerging novel biomaterials and their potential in healthcare in short proof of concept studies. They encourage any companies that can see application of these technologies in their area to contact the panellists in the discussion session or send us an email. Please click here to contact the team. \n  \nSPEAKER PROFILES: \n \nProfessor Morgan Alexander\, Professor of Biomedical Surfaces\, University of Nottingham \nMorgan Alexander is Professor of Biomedical Surfaces\, the Director of the EPSRC Programme Grant in Next Generation Biomaterials Discovery and a Wellcome Trust Senior Investigator based in the School of Pharmacy at the University of Nottingham. He received his BSc in Materials (1988) and his PhD from the same department at The University of Sheffield in 1992. \nHis work involves developing materials for application in human healthcare and characterising relationships between surface structure and biological properties. Understanding these relationships is critical to the development of next generation biomaterials and it is the theme running through his group’s work across a variety of areas spanning control of bacterial adhesion\, to engineering cell response with applications in medical devices and cell manufacture. \n \nKiril Kalenderski\, PhD Student\, University of Nottingham \nKiril is a researcher at the University of Nottingham\, studying biofilm formation on bio-material surfaces developed as medical device coatings. He has predominantly worked with indwelling urinary catheters\, to determine the efficacy of bio-material coatings in reducing biofilm formation on these devices\, within in vitro experiments and clinical settings. \n  \n  \nDr Robert Cavanagh\, Research Fellow\, University of Nottingham \nRob completed his PhD in Drug delivery in 2017 at the University of Nottingham and focused on investigating intestinal permeability enhancers for the delivery of biologics. He joined Professor Cameron Alexander’s group in December 2017 as a post-doctoral researcher studying chemotherapeutic delivery using novel polymeric nanoparticles. \n  \n  \nDr Patrícia Monteiro\, Research Fellow\, University of Nottingham \nPatrícia received a B.Sc. and M.Sc. in Pharmacy and Pharmaceutical Sciences from the Federal University of Ouro Preto (UFOP)\, Brazil. In 2019 she completed her Ph.D. in drug delivery at the University of Nottingham. She then joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher. Her current research is focused on the development of bioresponsive polymers for triple negative breast cancer therapy. \n  \n  \n  \nDr Leanne Fisher\, Research Fellow\, University of Nottingham \nSchool of Life Sciences\, Immunology and Immuno-bioengineering Group \nLeanne’s research has focussed on the design and development of antimicrobial/anti-fouling surfaces to prevent the formation of biofilms on medical devices. More recently\, she has been studying the impact of surface engineering on immune modulation and prevention of the foreign body response. Alongside this\, Leanne works in developing immune-competent biomimetic tissue models\, specifically organ-on-a-chip models. \n  \n \nDr Matthew Vassey\, Research Fellow\, University of Nottingham \nMatthew received a B.Sc. in Microbiology and Cellular Biology in 2005 at the University of Nottingham. In 2014 he completed his Ph.D. in Cellular Microbiology also at the University of Nottingham. He joined the EPSRC Programme Grant in Next Generation Biomaterials Discovery as a post-doctoral researcher in November 2017. His current research is focused on cell biology\, human iPSC derived cells\, 3D biology\, host-pathogen interactions and infection biology. \n  \n  \n \nArsalan Latif\, PhD Student\, University of Nottingham \nArsalan is a final year doctoral student researching in developing stromal instructive niches to promote healing and suppress fibrosis\, at the University of Nottingham. Before which he did his master’s in biomedical engineering at Chalmers University of Technology\, Sweden. Besides science\, he enjoys building Lego models in his spare time. \n 
URL:https://www.medilinkmidlands.com/event/commercial-applications-for-next-generation-biomaterials/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Morgan-Alexander.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20260403T195312
CREATED:20200923T090623Z
LAST-MODIFIED:20200923T090623Z
UID:18378-1601546400-1601550000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Manufacturing Face Masks and PPE - what you need to know
DESCRIPTION:SGS Webinar demystifies face mask and PPE Certification for manufacturers \nSGS’s webinar\, in association with Medilink Midlands\, will explain in simple terms the steps that manufacturers must take to place personal protective equipment (PPE) and face masks on the market. \nThe pandemic has led to exponential growth in PPE demand\, with the market now projected to reach $85.72 billion (£67.87 billion) by 2026 according to Fortune Business Insights – a compound annual growth rate of 7.3%. \nTo take advantage of this lucrative market\, many companies are pivoting to include PPE manufacturing in their products and services or expanding into new geographies\, such as overseas manufacturers entering the UK market. Lancashire Textiles\, for example\, has switched from producing duvets\, blankets\, and towels to manufacturing face masks. 3D Folkes has been supplying NHS workers with 3D printed face shields. \nHowever\, new entrants to the market are finding themselves caught in a maze of requirements to have products certified to sell in the UK as PPE. These processes can be easily misunderstood – especially among the confusion and noise that the pandemic has created. \nTo help manufacturers understand the different types of PPE\, and the testing and certification process\, SGS experts Kevin Foy and Kelvin Shepherd will cover everything you need to know about getting your products placed on the market. \nAt the end of this one-hour session\, attendees will have the opportunity to pose their questions. As part of a global network of PPE experts and accredited laboratories\, both Kevin and Kelvin are well placed to advise on how you can ensure the compliance of your face masks and PPE products. \nThis webinar will help you to understand the steps you need to take and the timeframes involved to get your goods to market. \nTo find out more and to book your free place\, please click here. 
URL:https://www.medilinkmidlands.com/event/webinar-manufacturing-face-masks-and-ppe-what-you-need-to-know/
CATEGORIES:Medilink Partner Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200930T110000
DTEND;TZID=Europe/London:20200930T120000
DTSTAMP:20260403T195312
CREATED:20200902T133927Z
LAST-MODIFIED:20200902T133927Z
UID:18346-1601463600-1601467200@www.medilinkmidlands.com
SUMMARY:WEBINAR: Clinical Trial - Design or Disaster?
DESCRIPTION:Join this ‘Clinical Trial – Design or Disaster?’ webinar to hear from Afortori Development and Simplified Data. This one hour webinar will explore: \n– Why is diligent and robust trial design needed?\n– What does it need to prove?\n– How complex does it need to be?\n– What kind of analysis needs to be undertaken? \nAttend to learn about the above and take the opportunity to get your questions answered by the experts. \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nDanielle Bodicoat\, Medical Statistics & Writing Consultant\, Simplified Data\nDanielle has over 12 years of experience as a medical statistician and writer with extensive experience of designing\, conducting and analysing clinical trials. She began her career researching the causes of breast cancer at the Institute of Cancer Research (University of London). She then went on to be a researcher and lecturer at the University of Leicester\, with a focus on diabetes. After a period working at Walgreens Boots Alliance to gain industry experience\, Danielle set up Simplified Data in 2019.  Danielle has a wealth of research\, statistics and writing experience. Danielle has particular expertise in diabetes and cardiovascular disease trials. Danielle has a PhD in Epidemiology\, MSc in Medical Statistics (Distinction) and BSc in Mathematics with Statistics (1st Class). \nNicola Wall \, along with Elizabeth Ralph founded Afortiori Development after long careers in clinical research within a variety of roles. Both bring a commitment to well designed and successfully executed clinical trials. \n\nDr Nicola Wall\, Chief Executive Officer\, Afortori Development  \n\nElizabeth Ralph\, Chief Operating Officer\, Afortori Development \n\nCharlotte Culver\, Clinical Project Leader\, Afortori Development\nCharlotte has a strong project management background in clinical research Phases I-V while delivering both commercial and non-commercial research throughout her career to produce quality results.\nShe is experienced in both pharmaceutical and device trials across several disease areas throughout the lifecycle of the project\, in collaboration with key pharmaceutical and device companies in the industry.\nHer proven project management track record provides her with the tools to deliver excellence and detailed delivery in clinical\, regulatory\, and financial aspects of clinical research.\nThroughout her research career\, she has worked on projects internationally\, as either multicentered or single-centre as lead. \n 
URL:https://www.medilinkmidlands.com/event/webinar-clinical-trial-design-or-disaster/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Danielle-Bodicoat.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200929T130000
DTEND;TZID=Europe/London:20200929T140000
DTSTAMP:20260403T195312
CREATED:20200907T110101Z
LAST-MODIFIED:20200907T110101Z
UID:18364-1601384400-1601388000@www.medilinkmidlands.com
SUMMARY:Medilink East Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink EM for an afternoon virtual coffee break on Tuesday 29 September at 1.00pm. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nThis virtual coffee break will provide the opportunity to hear an update on our recent activity\, in particular plans for Medilink Midlands. \nGrab a coffee\, a biscuit and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only
URL:https://www.medilinkmidlands.com/event/medilink-east-midlands-virtual-coffee-break-members-only-2/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200928
DTEND;VALUE=DATE:20200929
DTSTAMP:20260403T195312
CREATED:20190923T123050Z
LAST-MODIFIED:20190923T123050Z
UID:18015-1601251200-1601337599@www.medilinkmidlands.com
SUMMARY:SEHTA's 1st International MedTech Expo & Conference
DESCRIPTION:The SME focused healthcare event for driving collaborations between Business\, Care & Clinicians & Academics \nSEHTA’s 1st International MedTech Expo & Conference \nDevices\, Diagnostics\, Digital\nAt one EVENT & in one DAY \nOver the last 15 years\, South East Health Technologies Alliance (SEHTA) has developed an excellent reputation for support of its 1\,300 members\, especially SMEs\, through its one to one mentoring\, fund-finding\, consultancy and events programme. \nIn 2020\, for the first time\, SEHTA is organising a major new international event in London designed to take the programme of support to another level. \nWe cordially invite you to join us on Thursday 26th March 2020 for SEHTA’s first International MedTech Expo & Conference taking place at the Hilton London Tower Bridge. This event is aimed at SME’s\, Corporates\, Academics & NHS Healthcare Providers. \nThe conference and expo aims to help delegates: \nUnderstand: Make sense of the complexities of healthcare support and challenges of accessing the NHS \nFind: Funding opportunities (public sector\, private\, NHS) \nNavigate: Regulatory\, legal and IP issues \nIdentify: Current clinical challenges in the NHS \nAnd perhaps most of all…. Make new contacts leading to collaborative partnerships at the event and through our bespoke 1:1 partnering website\n(available from January 2020 to book your meetings) \nFor further information\, please click here to email SEHTA.
URL:https://www.medilinkmidlands.com/event/sehtas-1st-international-medtech-expo-conference/
LOCATION:Hilton London Tower Bridge\, 5 More London Riverside\, London\, SE1 2BY
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200924T103000
DTEND;TZID=Europe/London:20200924T120000
DTSTAMP:20260403T195312
CREATED:20200819T071659Z
LAST-MODIFIED:20200819T071659Z
UID:18317-1600943400-1600948800@www.medilinkmidlands.com
SUMMARY:WEBINAR: AI and Smart-Tech in the Home
DESCRIPTION:This webinar will explore AI and Smart-Tech in the Home\, take the opportunity to hear from Research Associates and Industry on this topic.  This event is in partnership with The Open University Faculty of Wellbeing\, Education and Language Studies. \nThe presenters will cover: \n– The MK:Smart programme\, a smart city initiative update and future directions for the smart city using the example of a hypothetical smart project using robots to encourage people to engage in active travel\, supporting healthy ageing and reducing social isolation \n– Hear from Pantri\, a company who embed AI into home appliances \n– Home assistance robots \n– A brief historical overview of robotic assistants plus overview of ‘Gatekeeper’ project including details on the application and it’s functionalities \nDURATION: 1.5 hours \nThis free to attend event is held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles:\n\nGaynor Henry-Edwards\, Research Manager\, Faculty of Wellbeing\, Education and Language Studies – The Open University \nGaynor manages the Health and Wellbeing Strategic Research Area at The Open University. The Strategic Research Area supports\, coordinates and promotes health and wellbeing research across the university. Open University researchers conduct research in health and wellbeing across various disciplines and areas including healthcare management\, ageing studies\, reproductive and sexual rights\, assistive technologies\, patient data management\, mental health and biological health sciences. The scope of University expertise ranges from the science underpinning health and disease through to the medical humanities. The Open University is committed to working towards social justice specialising in participative and inclusive research methods with marginalised and vulnerable communities. \n\nMiguel Valdez\, Lecturer in Technology and Innovation Management\, School of Engineering and Innovation – The Open University\nMiguel began his career as a software engineer\, went on to become a technology journalist and is currently working as a Research Associate in the School of Engineering and Innovation at the Open University. His doctoral research interrogated sustainable transport pilots in Milton Keynes\, with a particular focus on the sensemaking activities that took place in organisations. He further developed this understanding of cities as experimental spaces within the transport work package of MK:Smart\, a £16 million smart city programme. Through his research\, Miguel has explored the role of innovative technologies in envisioned and developing future urban environments. His research has drawn insights from urban geography and innovation studies to interrogate how the experimental spaces in cities may facilitate the development of new knowledge about sustainable innovation\, and on how such knowledge coalesce and travel. \n\nTom Cooper\, CEO\, Pantri\nTom is the CEO and founder of Pantri – a new platform which aims to make the new breed of WiFi connected kitchen appliances shop for repeat purchases automatically.  He is considered a thought leader in the smart kitchen industry\, with regular appearances in industry publications where he shares his views on how over the next 10 years\, a lot of the weekly shop is going to become a lot easier and automated thanks to exciting new IoT and AI breakthroughs. \n\nGianluca Bardaro\, Research Associate\, Knowledge Media Institute – The Open University \nGianluca’s area of research is robotic software development. In particular\, he is interested in how to enhance the existing tools and approaches to streamline the development process and achieve more complex\, robust and functionality-rich robot applications. Currently\, he is involved in the GATEKEEPER European project\, as a task leader. As part of this project\, his aim is developing a robotic assistant which operates within a smart home environment and which is capable of addressing the healthcare needs of elderly people.
URL:https://www.medilinkmidlands.com/event/webinar-ai-and-smart-tech-in-the-home/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/GaynorHenryEdwards_OU.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200923T110000
DTEND;TZID=Europe/London:20200923T120000
DTSTAMP:20260403T195312
CREATED:20200212T133227Z
LAST-MODIFIED:20200212T133227Z
UID:18064-1600858800-1600862400@www.medilinkmidlands.com
SUMMARY:Webinar: Precision Imaging- transforming healthcare and nutrition with pioneering imaging
DESCRIPTION:Join this webinar with the University of Nottingham where they will showcase the latest developments and capabilities in precision imaging. \nTopics will include innovations in the application of imaging tools to:\n-Pharmaceuticals\n-Nutrition in food and beverages\n-Medical Devices\n-Biomarkers for health \nThere will also be an opportunity to ask your questions directly to the presenters in a Q&A session. \nA wide range of available expertise will be explored from medicine\, physics\, mathematics\, psychology\, life sciences and computer sciences. Information will also be presented on the facilities dedicated to research full time\, so you can find facilities and expertise to help with your product development. \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project.  This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \nProfessor Dorothee Auer\, Professor of Neuroimaging\, MD\, PhD  \nDirector\, Precision Imaging Beacon of Excellence\, Imaging Theme Lead\, NIHR ~Nottingham BRC \nDorothee’s research interest is to develop imaging biomarkers in Clinical Neurosciences using advanced MRI techniques. Aims are: (1)understand the pathophysiology of diseases/complex symptoms across diseases\, (2)improve diagnostic accuracy\, (3)predict and assess therapeutic interventions. Methods include MR proton spectroscopy\, diffusion tensor imaging\, perfusion\, relaxometry\, high resolution carotid imaging and combined electrophysiological/fMRI. \nProfessor Luca Marciani\, Precision Imaging Beacon\, Industrial Strategy and Business Engagement Lead\, University of Nottingham \nLuca’s expertise is in imaging the human gastrointestinal (GI) tract using MRI. His research focuses on GI physiology/pathology using MRI combined with other techniques. Luca is interested in in-body imaging of foods\, beverages\, dosage forms and formulations\, intestinal fluid distribution and developing novel MRI tests for GI motility and transit. \n  \n 
URL:https://www.medilinkmidlands.com/event/precision-imaging-transforming-healthcare-and-nutrition-with-pioneering-imaging/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Dorothee-Auer.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200922T103000
DTEND;TZID=Europe/London:20200922T113000
DTSTAMP:20260403T195312
CREATED:20200818T151840Z
LAST-MODIFIED:20200818T151840Z
UID:18333-1600770600-1600774200@www.medilinkmidlands.com
SUMMARY:Webinar: Is your Business Case NHS Ready?
DESCRIPTION:Join the second of our two-part CPD accredited virtual workshops\, Is your Business Case NHS Ready?\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nThe challenge as innovators and companies selling to the NHS is often that when you have a product that improves patient outcomes and saves cost you still cannot get it adopted by the NHS. This is frequently because there isn’t a fully developed business case. \nPART 1 is a pre-recorded 40 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– What a business case is\, what is its purpose and why is it so important? \n– Who reviews the business case and how are they evaluated? \n– How to construct a good business case \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Tuesday 22nd September. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \n Nicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://www.medilinkmidlands.com/event/webinar-is-your-business-case-nhs-ready/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T140000
DTEND;TZID=Europe/London:20200917T150000
DTSTAMP:20260403T195312
CREATED:20200810T091846Z
LAST-MODIFIED:20200810T091846Z
UID:18315-1600351200-1600354800@www.medilinkmidlands.com
SUMMARY:Diagnosing the risk in diagnostics development; man versus machine
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nThe design and development of Diagnostic devices within the medical industry is a complex process\, fraught with usability uncertainties. Many clinicians are reluctant to make a diagnosis without the confirmation of a device\, but devices cannot always be used in isolation as they do not have the full picture and patient knowledge of the clinician. This dichotomy makes the development of such devices often difficult. So\, how do we develop a diagnostics device which satisfies the product\, patient\, and clinician requirement specifications? Furthermore\, how can we develop a diagnostics strategy that addresses the codependence of diagnostic devices and their user? \nThis webinar will focus on what it takes to produce a diagnostics device which not only meets requirements but lives up to its marketing. Looking at the user and usability requirements\, how your device should be classified and the importance of creating a defined strategy\, we will discuss the human factors involved with diagnostics design and how total reliance on the device is not always the best option.  \nTopics to be covered include: \n\nThe key considerations in a diagnostics device development programme\nThe importance of identifying your product strategy early in your programme\nHow to keep usability and the end-user in mind throughout\nNavigating the regulatory process\nClosing the design loop – ensuring your end product does what you say it does!\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details\, and to book your place\, click here
URL:https://www.medilinkmidlands.com/event/diagnosing-the-risk-in-diagnostics-development-man-versus-machine/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200917T103000
DTEND;TZID=Europe/London:20200917T120000
DTSTAMP:20260403T195312
CREATED:20200806T073511Z
LAST-MODIFIED:20200806T073511Z
UID:18304-1600338600-1600344000@www.medilinkmidlands.com
SUMMARY:WEBINAR: Infectious Diseases Special Interest Group (SIG) - Infection Control during COVID-19: Masks\, hands and surfaces
DESCRIPTION:The next Infectious Diseases Special Interest Group will take place online and the focus will be on Infection Control during COVID-19: Masks\, hands and surfaces. \nThis event is in partnership with De Montfort University and led by Dr Katie Laird\, Reader in Microbiology and also Head of the Infectious Disease Research Group at De Montfort University. Presentations will be given on: \n– Masking the masses: Efficacy and controversies of face masks\n– Surface Disinfection\, hand sanitation and COVID-19.  What have we done\, and what should we have done?\n– Supporting the NHS during COVID-19 \nDURATION: 1.5 hours \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £190\, but is delivered completely free of charge to participants. \nSpeaker Profiles: \n\nDr Katie Laird\, Head of the Infectious Disease Research Group at Leicester School of Pharmacy\, De Montfort University \nKatie has a BSc (Hons) in Biology and obtained a PhD in applied microbiology in 2008. During her PhD she developed and patented an essential oil based antimicrobial vapour\, whilst her postdoctoral work included the assessment of natural antimicrobials efficacy against post-harvest pathogens.\nHer research interests include the use of natural products as antimicrobials in particular to combat hospital acquired infections and biofilms.  Her other area of research includes the assessment of healthcare laundry as a potential route of cross contamination in the clinical arena. \n \nDr Maitreyi Shivkumar\, Lecturer in Molecular Biology at Leicester School of Pharmacy\, De Montfort University\nMaitreyi is a virologist and lecturer in De Montfort University. Her research has focussed on host-pathogen interactions in the context of entry and transmission of viruses. She has recently established her lab at the Leicester School of Pharmacy\, where she is working on developing broad-spectrum antivirals as well as investigating infection control strategies against coronaviruses. \n\nDr Andrew Kemp\, Principal Scientific Officer\, Q Technologies\nAndrew holds a PhD in surface disinfection and decontamination. His specialist area of research is testing for bio burden\, long term disinfection and decontamination. Dr Kemp consults for BICSc\, governments\, private organisations and companies. He is regarded as a global expert in his specialist area of work\, undertaking research at the University of Lincoln and the University of Baltimore. He is a member of the steering group for the UK Infectious Diseases Research group. He recently completed writing the environmental cleaning and disinfection guide and standards for the UK NHS Improvement organisation. \n\nLinda Knight\, Training Specialist\, Pal International\nLinda has worked in medical consumables for over 25 years as a business development manger and specialist trainer primarily in the infection prevention sphere. Linda currently works for Pal International in the MediPal division. She has a keen interest in cooking having trained as a chef and loves to spend time with her grandchildren.
URL:https://www.medilinkmidlands.com/event/webinar-infectious-diseases-special-interest-group-sig-infection-control-during-covid-19-masks-hands-and-surfaces/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Katie-Laird.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T140000
DTEND;TZID=Europe/London:20200916T150000
DTSTAMP:20260403T195312
CREATED:20200810T091604Z
LAST-MODIFIED:20200810T091604Z
UID:18314-1600264800-1600268400@www.medilinkmidlands.com
SUMMARY:Microfluidics; small technology\, big pitfalls
DESCRIPTION:Series of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nIt is estimated that the Global Microfluidics Market will have a value of over USD 53 billion by the end of 2027\, but how much do you really know about Microfluidics and how it fits in to a design programme? \nThis webinar will look at the various development challenges when working with Microfluidics. Starting with an overview of applications and fabrication technologies\, we will then discuss the relationship between single use consumables and multi-use products with examples\, the different fluid handling technologies and then move on to the main developmental obstacle; identifying\, assessing and overcoming the many pitfalls associated with Microfluidics. \nThis webinar will cover: \n\nAn overview of Microfluidics and how it is incorporated into development programmes\nUnderstanding the different technologies available and identifying the most suitable option for your programme\nThe importance of identifying and assessing risks early in your programme and overcoming these development challenges\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more details and to book\, click here
URL:https://www.medilinkmidlands.com/event/microfluidics-small-technology-big-pitfalls/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200916T130000
DTEND;TZID=Europe/London:20200916T143000
DTSTAMP:20260403T195312
CREATED:20200626T134819Z
LAST-MODIFIED:20200626T134819Z
UID:18244-1600261200-1600266600@www.medilinkmidlands.com
SUMMARY:Webinar: Life Sciences Opportunities in Wallonia\, Belgium
DESCRIPTION:Wallonia\, the French-speaking region of Belgium\, is one of the key references in the field of life sciences\, as it occupies a pivotal role for the European and global pharmaceutical industry thanks to a unique ecosystem. The ongoing efforts to improve the business environment in the region have allowed companies to improve their competitiveness through lower costs and easier access to facilities and qualified workforce. This is why the region has been chosen to produce the active substance for the AstraZeneca vaccine against covid-19. \nIf your company wishes to learn about Wallonia’s unique advantages and is thinking about expanding to Mainland Europe\, you are welcome to attend this webinar. AWEX\, the Walloon Agency in charge of Foreign Trade and Investment\, will present the region’s ecosystem. \nThe webinar will cover:\n– The Walloon ecosystem for the life sciences industry\n– The Biowin Cluster\n– The 6 strategic domains: (bio)pharmacy\, cell therapy\, radiation applied to health\, medical devices and in vitro diagnostics\, biomanufacturing\, data science\n– The Science Parks Network\n– The 2 potential partners: BioPark Charleroi & Louvain la Neuve Science Park \n-The Belgian tax regime \n-Tax incentives for R&D & IP in Belgium \n-Financial incentives \n– Cash grants \n-Subsidies for foreign companies \n-Welcome office \nThere will also be the opportunity to ask questions directly to the speakers. \nTO BOOK YOUR PLACE\, PLEASE CLICK HERE\nSpeaker Profiles: \nMaxime Couvreur\, Trade & Investment Counsellor\, The Embassy of Belgium – AWEX \n  \n  \n  \n  \nLaurence Slangen\, Business Relations Manager\, SPI Agency (Liège Region)/Representative of the SpoW (Science Parks of Wallonia) Network \n  \n  \n  \nMarc Dechamps\, Director of International Affairs\, Biowin Cluster\, Wallonia \n  \n  \n  \n \nNicolas Honhon\, Tax Expert & Brexit Expert – Fiscal Department\, Foreign Investment of the Federal Public Service of Belgium. (based in the Belgium Embassy in London) \n  \n  \n  \n  Régis César\, Scientific advisor\, department of research & innovation\, Walloon administration \n  \n 
URL:https://www.medilinkmidlands.com/event/webinar-life-sciences-opportunities-in-wallonia-belgium/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Maxime-Couvreur.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T140000
DTEND;TZID=Europe/London:20200915T150000
DTSTAMP:20260403T195312
CREATED:20200810T091214Z
LAST-MODIFIED:20200810T091214Z
UID:18313-1600178400-1600182000@www.medilinkmidlands.com
SUMMARY:The Killer Issue: How to mitigate risk when designing in-vivo devices
DESCRIPTION:SEHTA & eg technology  \nSeries of In-vivo devices\, Microfluidics and Diagnostics Webinars \nSeptember 2020 \nSEHTA and eg technology are delighted to announce a series of webinars on the topics of In-vivo devices\, Microfluidics and Diagnostics to enable you to continue to update your skillset and move your medical technologies and companies forward. \nEach session will run for 1 hour:  14:00 – 15:00 (UK time) \nThese webinars will be run via WEBEX – details on application \nRisk goes hand in hand with medical device design and development – intervening in the human body will always have the potential to go wrong. But what happens when device limitations could result in serious injury or even death? Join egt director\, Danny Godfrey as he looks specifically at the design and development of in-vivo devices and how risks are identified\, managed\, and mitigated to minimize the risk of potentially catastrophic outcomes. \nStarting with a brief overview of the medical device development process\, this webinar will address the importance of examining the full use cycle of your device and identifying risks early on in your project – including less obvious and sometimes unseen obstacles – whilst ensuring full traceability throughout. \nTopics to be covered include: \n\nThe key things to consider from the outset of any development programme\nHow to identify the full spectrum of potential risks \nWhen in your programme this should happen\nThe importance of device classification and mapping risks against standards\nHow to mitigate risks to allow you to get on with your design\n\nTarget audience for these webinars are: Medical Technology Entrepreneurs\, Medical Device Software Developers\, Technology Transfer Officers\, Medical Technology University Researchers\, IVD Developers\, Business Owners\, Executives\, Product Owners\, Regulatory Specialists within a company that need to understand the overall regulatory requirements for their medical devices to enable them to place a device on the market and to maintain access. All company sizes will find it useful. \nCosts to attend: \nEarly bird rate – book by 31st August 2020 \n£55 + VAT pp per webinar for members / £65 + VAT non-members \nAfter 31st August 2020 \n£65 +VAT pp per webinar for members / £75 + VAT non members \nNot a member of SEHTA – it’s free to join – https://www.sehta.co.uk/Post/sehta-membership \nFor more information and to book\, click here
URL:https://www.medilinkmidlands.com/event/the-killer-issue-how-to-mitigate-risk-when-designing-in-vivo-devices/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200915T083000
DTEND;TZID=Europe/London:20200915T093000
DTSTAMP:20260403T195312
CREATED:20200827T153500Z
LAST-MODIFIED:20200827T153500Z
UID:18345-1600158600-1600162200@www.medilinkmidlands.com
SUMMARY:Medilink East Midlands Virtual Coffee Break - Members Only
DESCRIPTION:Join Medilink EM for an early morning virtual coffee break on Tuesday 15 September at 8.30am. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nThe theme of today’s coffee break will be ‘How has your marketing changed?’ \nGrab a coffee and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only \n 
URL:https://www.medilinkmidlands.com/event/medilink-east-midlands-virtual-coffee-break-members-only/
CATEGORIES:Medilink Midlands Event
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200910T103000
DTEND;TZID=Europe/London:20200910T113000
DTSTAMP:20260403T195312
CREATED:20200818T144321Z
LAST-MODIFIED:20200818T144321Z
UID:18332-1599733800-1599737400@www.medilinkmidlands.com
SUMMARY:Webinar: Introduction to NHS Market Access
DESCRIPTION:REGISTRATION FOR THIS SESSION IS NOW CLOSED. The next date for this webinar is Wednesday 21st October. To register\, please click here. \nJoin our two-part CPD accredited virtual workshop\, Introduction to NHS Market Access\, delivered by the East Midlands Academic Health Science Network (EMAHSN). \nCombined\, the two sessions will give innovators key insights into the complexities of the NHS and wider healthcare ecosystem as well as the support available to help you to introduce your health technology product or service into the NHS. \nPART 1 is a pre-recorded 45 minute webinar that you can watch at a time convenient to you. \nThe webinar will cover: \n– The NHS Structure \n– Understanding pathways and cash flow \n– Getting your message right \n– What support you can expect from the AHSN \n—————— \nPART 2 is a live 1-hour Q&A session that will take place on Thursday 10th September. \nIn order to gain access to this live session\, delegates are required to watch the pre-recorded webinar prior to attending.  \nThe Q&A session will be held with a panel of experts from the EMAHSN and delegates will have the opportunity to ask questions directly to the team. \nThis free to attend virtual event will be held as part of the ACTIS programme – a project part-funded by the European Regional Development Fund. Click here to be redirected to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £222\, but is delivered completely free of charge to participants. \nUpon registration you will be sent a link to the pre-recorded webinar by a member of the Medilink East Midlands events team.  Joining details for the live Q&A session will be distributed separately once the webinar has been viewed.  \nSPEAKER PROFILE: \nNicholas Brown\, Commercial Manager\, East Midlands Academic Health Science Network \nNick joined the East Midlands Academic Health Science Network as Commercial Manager in 2015. Prior to this\, Nick has more than 20 years’ experience of the medical industry working with manufacturers\, distributors and clinical staff from the UK and European health sectors\, from both the sales and marketing side\, as well as in a consulting and advisory role. His Commercial Manager role focuses on building closer links between healthcare and businesses; identifying new services and products that can be introduced for the benefit of patients throughout the region – as well as marketed throughout the UK and abroad\, providing wealth creation opportunities across the East Midlands.
URL:https://www.medilinkmidlands.com/event/introduction-to-nhs-market-access-3/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/erdflogo2.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200910T100000
DTEND;TZID=Europe/London:20200910T110000
DTSTAMP:20260403T195312
CREATED:20200810T113723Z
LAST-MODIFIED:20200810T113723Z
UID:18316-1599732000-1599735600@www.medilinkmidlands.com
SUMMARY:R&D Tax Credits and Accounting for Development Expenditure
DESCRIPTION:Have you recently applied for UK Government funding grant or recently been awarded one?  Then this is the webinar for you! \nSEHTA and Edwards Chartered Accountants are pleased to launch their first webinar on R&D tax credits and accounting for companies who are engaged in developing new science or technology and who have recently received or in the process of applying for a UK government grant.\nDate: Thursday 10th September 2020 \nTime: 10:00 – 11:00 (UK Times) \nCosts: SEHTA Members: £65 + VAT per delegate / Non-Members:  £75 + VAT per delegate\n​Not a member of SEHTA? – it’s free to join\nThese webinars will be run via WEBEX – details on application \nOverview of the webinar \nR&D tax credits: \n\nDetails of the two schemes which are available (Small & RDEC)\nExample calculations to demonstrate the tax savings / refunds available to companies\nDetails of the procedure of making an R&D claim\nDetails of what costs qualify for R&D tax credits and eligibility criteria\nDetails of proposed future changes to the scheme and COVID-19 related tips\n\nAccounting for development expenditure: \n\nDetails of the two options available to companies\nPros and cons of both options and why a company may want to consider changing their accounting policy for development expenditure\nDetails of the procedure which can be implemented if a company decides to change its accounting policy for development expenditure including eligibility criteria\n\nTarget audience:  Any company which is engaged in developing new science or technology\, and any company which is currently in the process of applying for or has recently received a UK government grant. \nPlaces are limited so register today to guarantee your place \nClick here to book
URL:https://www.medilinkmidlands.com/event/rd-tax-credits-and-accounting-for-development-expenditure/
CATEGORIES:Medilink Partner Event
ORGANIZER;CN="SEHTA":MAILTO:info@sehta.co.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200908T110000
DTEND;TZID=Europe/London:20200908T120000
DTSTAMP:20260403T195312
CREATED:20200817T082646Z
LAST-MODIFIED:20200817T082646Z
UID:18327-1599562800-1599566400@www.medilinkmidlands.com
SUMMARY:Webinar: How does the demise of the Privacy Shield impact Life Sciences businesses?
DESCRIPTION:[box type=”shadow” align=”” class=”” width=””]We have unfortunately had to postpone this webinar. We sincerely apologise for this inconvenience and will update our website with further information of a new date as soon as this becomes available. If you have any questions\, please email us at info@medilinkem.com\, or call us on 0115 822 3154. [/box] \nAt the end of July\, the European Court of Justice struck down the US Privacy Shield\, and although it focused on EU-US data transfers\, the ruling is already causing widespread aftershocks for international personal data transfers within the EEA. International group companies using personal data\, or even non-international organisations which are using Cloud or other service providers in non-EEA countries (such as India or elsewhere)\, need to be aware of the implications arising from the ruling. \nFor life sciences businesses\, the kinds of data that may be affected could be data about individual patients and their treatment\, clinical trial data and information about staff\, research colleagues and physicians. Organisations have become so used to working digitally that they may not even fully appreciate when international data transfers are taking place. \nJagvinder Singh Kang\, International and UK Head of IT at Mills & Reeve considers what steps you can take to protect your organisation following the ruling. \nThis webinar will be relevant to all organisations involved in international personal data transfers from within the EEA\, whether to group companies\, service providers or other organisations. \nThere will also be an opportunity to ask the presenters questions\, when Jagvinder will be joined by for a Q&A session byspecialist Life Sciences Lawyer Stephanie Caird. \nDURATION: 1 hour \nPlease note that due to privacy restrictions this webinar will NOT be recorded and the presentation slide will not be available to download. \nThis free to attend webinar will be held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund. For further details please click here. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSPEAKER PROFILES: \n Jagvinder Singh Kang – International and UK Head of IT (CIPP/E\, CIPM) \nJagvinder is a market leading technology lawyer. He is featured in Legal 500’s official ‘Hall of Fame’ – which Legal 500 confirms: “highlights\, to clients\, the law firm partners who are at the pinnacle of the profession.” He has been recognised for 9 consecutive years in Legal 500’s ‘Elite List of Outstanding Technology Lawyers Nationwide’\, and consistently been ranked number one for IT and technology law by Legal 500 and Chambers & Partners for the same period. Jagvinder is a specialist technology and GDPR/data protection lawyer (CIPP/E\, CIPM)\, as well as a qualified software engineer (First Class BSc (Hons) Computer Science & Software Engineering) and he has completed the academic requirements for Chartered Engineer status as well. Furthermore\, he has over 20 years of technology law expertise from having advised on billions of pounds worth of UK and international technology transactions\, involving FTSE 100\, NASDAQ listed and other world-class corporates. He has also undertaken global\, European and UK GDPR compliance projects. \n  \n \nStephanie Caird – Commercial Lawyer \nStephanie is a lawyer in the life sciences practice\, with significant experience in data protection\, intellectual property\, commercial contracting and regulatory work. She supports a wide range of clients in the pharma and biotech\, medical devices and diagnostic sectors. Stephanie has worked in-house in various life sciences organisations\, giving her a unique insight into her clients. She uses this experience to deliver pragmatic and commercial advice. A key focus of her work is supporting clients on strategic decisions influenced by the regulatory framework and contracts covering IP\, research collaborations and Brexit related intra-group arrangements.
URL:https://www.medilinkmidlands.com/event/webinar-how-does-the-demise-of-the-privacy-shield-impact-life-sciences-businesses/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Jagvinder-Singh-Kang-scaled.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200904T130000
DTEND;TZID=Europe/London:20200904T143000
DTSTAMP:20260403T195312
CREATED:20200824T082519Z
LAST-MODIFIED:20200824T082519Z
UID:18336-1599224400-1599229800@www.medilinkmidlands.com
SUMMARY:Lifescience Industry News Industry Spotlight
DESCRIPTION:Examining the UK response to Covid-19\nAhead of the Lifescience Industry Magazine being published\, Lifescience Industry Magazine is hosting a webinar\, on 4th September at 1 pm\, spotlighting some of the great stories of how the UK has responded to the pandemic. \nShowcasing how the life science and health tech sector worked\, collaborated and persevered during these challenging times. \nEach of Lifescience Industry’s partners will be introducing companies from across the UK\, further program details to follow shortly. \nConfirmed speakers include: \n\nJames Hindley\, Executive Director of Indoor Biotech\nDr Roberto Liddi\, Senior Vice President Quality Regulatory and IG Compliance at Sensyne Health\nNeil Cambell\, Chief Executive Officer for Inspiration Healthcare Group\nSven Bunn\, Life Sciences Programme Director at Barts Health NHS Trust\n\nLifescience Industry magazine is a collaboration between regional\, national and international life science partners. It includes the latest news and developments from the life science industry\, with editorial covering the complete health technology spectrum\, as well as funding\, trade and collaboration opportunities. \nTo register for this event\, click here
URL:https://www.medilinkmidlands.com/event/lifescience-industry-news-industry-spotlight/
CATEGORIES:Medilink Partner Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200903T103000
DTEND;TZID=Europe/London:20200903T120000
DTSTAMP:20260403T195312
CREATED:20200312T142022Z
LAST-MODIFIED:20200312T142022Z
UID:18080-1599129000-1599134400@www.medilinkmidlands.com
SUMMARY:Webinar: How Healthy is Your Business?
DESCRIPTION:   \nJoin this Medilink Midlands webinar with BHIB Insurance for an insight into the current challenges faced by SMEs during this difficult time. \nThe webinar will cover: \n-Valuable business advice tailored to COVID-19 \n-How to trade successfully in difficult times \n-The cyber risks associated with working from home \n-Real life example Cyber-attacks & the importance of Cyber security \n-The importance of health and wellbeing in the workplace \nThere will also be an opportunity to ask questions to the presenters in a Q&A session. \nDuration: 1 hour & 30 minutes \nSpeaker Profiles: \n \nIan Stutz\, Managing Director Brokerbility \nIan Stutz has worked in the UK insurance industry for over 30 years. He spent 22 years at Aon\, culminating in a role on the UK Corporate Board.\nIan is on the board of Brokerbility Holdings and Managing Director of Brokerbility. Over the last 12 years he has developed a deep understanding of the issues facing independent community\, niche and specialist brokers. He has been able to take the experience gained in the corporate sector and help prepare the brokers he engages with for the challenges they face in a difficult economy to increased competition and the inevitable succession issues as the principal shareholders reach retirement age. \n  \n  \n \nAndy Hall\, Corporate Insurance Broker\, BHIB Insurance Brokers \nAndy has worked in the insurance industry for 22 years and for the last 3 years has headed up the specialist cyber risks division at BHIB insurance brokers working closely with clients and their IT teams to evaluate cyber security risks and recommending the appropriate risk management and insurance solution to meet their needs. \n  \n  \nEd Wright\, Partner\, Shakespeare Martineau \nEd works with clients on non-contentious contractual\, IP\, data protection and competition law issues\, with a particular focus on the healthcare/life sciences\, sport\, technology\, media and communications sectors. \nEd primarily advises on the creation\, ownership and exploitation of IP\, including licensing\, R&D/technology transfer and agency\, distribution\, reselling and franchising arrangements. \n  \n Adam Noach\, Head of Strategic Analytics\, Vitality Life \nAdam is the Head of Strategic Analytics at Vitality UK\, responsible for the analytical aspects of research initiatives\, with a particular focus on health and wellbeing in the workplace. \nHe joined Vitality UK in 2012\, after working for the parent company – Discovery – in South Africa for 11 years. \n  \n \nRichard Hewitt\, Account Executive\, BHIB Insurance Brokers \nRichard has worked in the UK Insurance industry for 20 years\, dealing with Commercial Risks for a number of leading global & UK insurance brokers.  Richard has been with BHIB for 9 years and advises a portfolio of clients on complex insurance matters\, ensuring their insurance programme fits their bespoke requirements.  During the past 4 years Richard has worked closely with Medilink East Midlands and gained a keen interest in the Life Science sector and the specific insurance needs of the sector.
URL:https://www.medilinkmidlands.com/event/how-healthy-is-your-business/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Ian-Stutz.jpg
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200901T133000
DTEND;TZID=Europe/London:20200901T143000
DTSTAMP:20260403T195312
CREATED:20200730T094611Z
LAST-MODIFIED:20200730T094611Z
UID:18303-1598967000-1598970600@www.medilinkmidlands.com
SUMMARY:Medilink EM Virtual Coffee Break - Members Only
DESCRIPTION:POSTPONED – Unfortunately we have had to postpone today’s virtual coffee break. This has been rescheduled to Tuesday 15th September at 8.30am To register please click here. \n  \nJoin Medilink EM for a virtual coffee break on Tuesday 1 September at 1:30pm. \nNetworking opportunities are one of the many Medilink EM member benefits and whilst the current COVID-19 crisis still won’t allow face to face events\, we have introduced an online opportunity to enable members to still connect with one another. This is an informal gathering\, hosted by Darren Clark\, our Chief Executive\, where you can share your current challenges and experiences and we can make introductions to those that can help. Or you could also join us just to see a friendly face and take time out from working at home. \nIf you have any topics that you’d like to discuss during the coffee break\, please feel free to email any suggestions to us by clicking here. \nGrab a coffee and join us. \nDial-in details will provided to delegates by a member of the Medlink EM events team once the online registration form has been completed. \nMedilink Members only \n 
URL:https://www.medilinkmidlands.com/event/medilink-em-virtual-coffee-break-members-only-8/
CATEGORIES:Medilink Midlands Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200826T090000
DTEND;TZID=Europe/London:20200826T100000
DTSTAMP:20260403T195312
CREATED:20200724T113548Z
LAST-MODIFIED:20200724T113548Z
UID:18293-1598432400-1598436000@www.medilinkmidlands.com
SUMMARY:Digital Marketing you can do in your Lab Coat
DESCRIPTION: Join Anicca Digital in this webinar designed for marketers or anyone working in medical\, health\, pharmaceutical or scientific sectors; who are responsible for promoting your brand\, products and services. \nAnn Stanley will introduce a range of digital marketing techniques that can be used to increase awareness for different target audiences and stakeholders. \nThe webinar will include \n-Some juicy stats from the world of digital marketing! \n–Introduction to digital marketing channels \n*Introducing the sales funnel \n*How does your target audience find your website \n*POET – Paid\, Owned\, Earned and Technical Media \n*Understanding your target audience and what channels can you use to get in front of them \n*An integrated approach to digital marketing \n–Practical digital marketing tactics you can start today  \n*Examples of audit and competitor research \n*What you should do if you have no marketing budget\, but time on your hands? \n*What channels should you use if you have marketing budget? \n–Introducing the A10 Marketing framework    \n-How can you learn more \nThere will also be an opportunity to ask your questions in a Q&A session \nSpeaker Profile: \nAnn Stanley – Founder and Managing Director of Anicca Digital \nAnn Stanley is the founder and MD of Anicca Digital\, with over 18 years’ experience of online marketing. She provides consultancy\, training on how to implement this framework across a range of digital marketing channels across Paid\, Owned\, Earned and Technical media (POET). The technical team at Anicca then provide digital marketing services to implement the strategy. \n 
URL:https://www.medilinkmidlands.com/event/digital-marketing-you-can-do-in-your-lab-coat/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/anicca3.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200825T110000
DTEND;TZID=Europe/London:20200825T120000
DTSTAMP:20260403T195312
CREATED:20200813T123408Z
LAST-MODIFIED:20200813T123408Z
UID:18326-1598353200-1598356800@www.medilinkmidlands.com
SUMMARY:WEBINAR: Building a health-economic model for the NHS
DESCRIPTION:Medilink Midlands and ORCHA invite you to attend a free webinar on Tuesday 25 August at 11am. \nORCHA is the world leading health app evaluation and advisor organisation\, helping governments\, health and social care organisations to choose and deliver health apps that will safely make the biggest impact to improve outcomes. \nSession overview: \nThis session will cover an introduction to the importance of digital health tools\, and the current digital health landscape in the NHS\, with Liz Ashall-Payne\, CEO at ORCHA. We will then hear from Simon Leigh\, Health Economist at ORCHA\, on how to build a health-economic model for the NHS. This will include an overview of what is needed\, where to obtain data\, modelling uncertainty and measuring effectiveness. \nObjectives: \n– Learn about the digital health landscape in the NHS \n– Learn how to build a health-economic model for the NHS \n– Ask the presenters any questions you may have \nBOOK YOUR FREE PLACE HERE
URL:https://www.medilinkmidlands.com/event/webinar-building-a-health-economic-model-for-the-nhs/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Medilink-Midlands-Logo-orange-final.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200820T103000
DTEND;TZID=Europe/London:20200820T113000
DTSTAMP:20260403T195312
CREATED:20200722T072032Z
LAST-MODIFIED:20200722T072032Z
UID:18289-1597919400-1597923000@www.medilinkmidlands.com
SUMMARY:East Midlands Academic Health Science Network Virtual Coffee Break
DESCRIPTION:A chance to hear more about the East Midlands Academic Health Science Network Digital Health Accelerator and how to apply for the next cohort. \nJoin EMAHSN for a virtual coffee break on Thursday 20 August at 10.30am. \nNetworking opportunities are a key part of Medilink EM events and whilst the current COVID-19 crisis won’t allow face to face events\, we have introduced this online opportunity to enable the life sciences community to still connect with one another. In this informal gathering\, hosted by Nick Brown\, Commercial Manager at EMAHSN\, you will have the opportunity find out how the EMAHSN can help innovators through the Digital Health Accelerator. \nGrab a coffee\, a biscuit and join us. \nJoining details will provided to delegates by a member of the Medilink EM events team once the online registration form has been completed. \nIf you have any topics that you’d like to discuss in future AHSN coffee breaks\, please feel free to email any suggestions to us by clicking here. \nChair Details: \n \n  \nNick Brown\, Commercial Manager\, EMAHSN
URL:https://www.medilinkmidlands.com/event/east-midlands-academic-health-science-network-virtual-coffee-break-3/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Badge-for-EMAHSN-Webinars.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200819T103000
DTEND;TZID=Europe/London:20200819T113000
DTSTAMP:20260403T195312
CREATED:20200709T153253Z
LAST-MODIFIED:20200709T153253Z
UID:18281-1597833000-1597836600@www.medilinkmidlands.com
SUMMARY:WEBINAR: Grant Application Writing Masterclass
DESCRIPTION:Join TBAT Innovation Ltd for a Grant Funding Masterclass\, delving into how to write a successful grant application for Innovate UK. \nKnowing how to write your grant funding application is the most important part of applying for innovation funding. \nMany competitions have success rates of below 10%; therefore\, your application needs to stand-out\, showcase your innovation and demonstrate your knowledge and expertise\, all within tight word-limits. \nThrough years of successfully helping businesses just like yours\, apply for Innovate UK funding competitions\, TBAT are experts in writing successful funding applications that will capture the assessor’s attention and highlight why your innovative project should be funded! \nDuring this 1-hour masterclass\, TBAT will cover:\n– The 10-question application form\n– How to answer each question\n– Their top tips for applying for Innovate UK funding\n– What to do if you need help applying \nThis is great opportunity to learn how to apply for current Innovate UK funding competitions such as the August round of Smart Grants and the Bio-Medical Catalyst and secure up to 70% of your project costs via these opportunities. \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nPlease note: this webinar is close to reaching the maximum number of delegates permitted\, if you are unable to book on the link below\, please email info@medilinkem.com requesting to be added to the waiting list. \nSpeaker Profiles: \nMatt Symonds\, Managing Director\, TBAT Innovation Ltd \nMatt Symonds joined TBAT Innovation in 2007 and shortly after became a Director of the business. He has a mechanical engineering degree and is an experienced project manager as a result of ten years’ experience in the Aerospace\, Power Generation and Rail sectors with companies like Rolls-Royce and Bombardier Transportation. \n  \n  \n Vincent Seddon\, Business Development\, TBAT Innovation Ltd \nVincent Seddon joined TBAT in 2019 to head up Business Development for their Oxford office after spending 10 years supporting Corporate clients to plan and grow their businesses as well as mentoring and coaching local business managers with the Barclays Business Bank.
URL:https://www.medilinkmidlands.com/event/webinar-grant-application-writing-masterclass/
ATTACH;FMTTYPE=image/png:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Vincent-Seddon.png
ORGANIZER;CN="Jo Rudzki":MAILTO:info@medilinkem.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200818T103000
DTEND;TZID=Europe/London:20200818T113000
DTSTAMP:20260403T195312
CREATED:20200723T134510Z
LAST-MODIFIED:20200723T134510Z
UID:18290-1597746600-1597750200@www.medilinkmidlands.com
SUMMARY:Medilink Midlands Virtual Coffee Morning
DESCRIPTION:Following the recent news of the amalgamation of Medilink West and East Midlands\, we bring you the next Medilink Midlands virtual coffee morning. \nAn informal gathering\, jointly hosted by Richard Stone\, Chief Executive at Medilink West Midlands and Dr. Darren Clark\, Chief Executive at Medilink East Midlands. \nAn opportunity to share current challenges and experiences and make introductions to those that can help. \nA chance to hear from our guest David Hillan\, Partner at Grant Thornton Birmingham who will provide a brief overview of the company and how it can help support SME businesses in the life sciences sector. \n                    \nWe’re here to help\, so let Medilink along with the virtual group work together to help each other with any concerns\, issues\, or solution needs you may have. If you have any questions or comments\, please feel free to submit in advance to make sure we cover your needs and meet expectations. \nWe hope you can join us. \nBOOK YOUR FREE PLACE HERE\nPlease note: Due to limited places\, bookings will be restricted to one representative per organisation.
URL:https://www.medilinkmidlands.com/event/medilink-midlands-virtual-coffee-morning/
CATEGORIES:Medilink Midlands Event
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/GTlogo-primary-strapline-CMYK2012-scaled.jpg
ORGANIZER;CN="Zoe Heather":MAILTO:info@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200813T110000
DTEND;TZID=Europe/London:20200813T120000
DTSTAMP:20260403T195312
CREATED:20200728T073330Z
LAST-MODIFIED:20200728T073330Z
UID:18298-1597316400-1597320000@www.medilinkmidlands.com
SUMMARY:WEBINAR: The COVID-19 catalyst - how the pandemic has optimised the opportunity for digital health
DESCRIPTION:Join Medilink East Midlands and Spirit Health Group to see how the COVID-19 pandemic has optimised the opportunity for digital health. \nAlthough the virus has been devastating for so many\, it has also accelerated development and adoption of technology across many areas of the healthcare system. \nIn this webinar\, Simon and Nadine will openly discuss the ups and downs of being at the forefront of remote healthcare delivery in Leicestershire. They will share insights about: \n– Working with the NHS during lockdown\n– How patients respond to change\n– The challenge of doing all this without ever having met face to face! \nDURATION: 1 hour \nThis free to attend event is held as part of the SoLSTICE programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profiles:  \n\nSimon Applebaum\, Managing Director\, Spirit Digital\nSimon is the Managing Director of Spirit Digital. He joined Spirit Health Group early in 2020 after 15 years of working in digital transformation in the travel and leisure industry and is passionate about the opportunity to transform and improve patient pathways through the use of technology. \n\nNadine Miles\, Director of Market Development\, Spirit Health Group\nNadine is Director of Market Development at the 10 year old healthcare company Spirit Health Group. Having graduated from Birmingham with a Business Studies degree and two post-graduate marketing qualifications\, she worked in banking\, retail\, and postal services before joining the NHS 19 years ago. With NHS roles within primary care\, secondary care\, mental health trusts and in the (now defunct) Strategic Health Authority\, she’s now in the independent sector focusing on making health easy for patients and clinicians within the NHS system.
URL:https://www.medilinkmidlands.com/event/webinar-the-covid-19-catalyst-how-the-pandemic-has-optimised-the-opportunity-for-digital-health/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Simon-Applebaum.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20200806T110000
DTEND;TZID=Europe/London:20200806T120000
DTSTAMP:20260403T195312
CREATED:20200721T141759Z
LAST-MODIFIED:20200721T141759Z
UID:18285-1596711600-1596715200@www.medilinkmidlands.com
SUMMARY:WEBINAR: The EU MDR Deadline Extension\, where are we now?
DESCRIPTION:This short webinar will explain what the latest timescales are\, and what changes have been made to the MDR since it was first published. Peter Rose\, Director of PRQR Ltd will go through the main points of change and provide practical advice on what to do in preparation for going live next year. The extension should not be seen as time for a break but more as time to get things right for a smooth and trouble free transition with no interruption to supply of your products to the EU market. The webinar will also briefly discuss Brexit and what we might expect from the new Medicines and Medical Devices Bill. \n– New deadline date\n– The Changes – 2 corrigenda\, a formal M1 revision including significant changes for Class I Devices\n– Notified Body Capacity – Act Now!\n– The B word (Brexit)\n– The new Medicines and Medical Devices Bill including the Cumberlege Review\n– Resources \nDURATION: 1 hour \nThis free to attend event is held as part of the INSTILS programme – a project part-funded by the European Regional Development Fund\, click here to be re-directed to further information about the project. This event is classed as State Aid to participating businesses\, the value of which is £127\, but is delivered completely free of charge to participants. \nSpeaker Profile:\n\nPeter Rose\, Director\, PRQR Ltd\nPeter is the founder and principal consultant of PRQR Ltd. With over 26 years of experience working in the field of Medical Devices and In Vitro Diagnostics\, Peter has expertise covering Quality Assurance\, Regulatory Affairs\, Sterilisation\, Cleanrooms and Contamination Control. \nPeter is a qualified Microbiologist\, a Chartered biologist\, Member of the Royal Society of Biology\, Practitioner Member of the Chartered Quality Institute and a Member of TOPRA. Peter has an abundance of experience and expertise in Quality\, Regulatory and microbiological matters for Medical Devices and IVDs across the UK and Europe. \nPeter possesses a range of technical and business skills that enable him to provide unique insight to new and emerging businesses. He takes a hands-on approach to challenges and is adept at creative problem-solving. As a highly driven and entrepreneurial business leader\, Peter has extensive senior leadership and board-level experience. As a well-regarded voice within the industry\, Peters holds the position of Director within Medilink East Midlands\, sits on a variety of industry committees and working groups and has been invited to address the European Parliament and Government ministers. \nPeter’s extensive experience includes the new Medical Device Regulation\, the new IVD Regulation the three established Medical Device Directives. He also has expertise in quality management systems covering ISO 9001\, ISO 13485 and 21 CFR 820 (QSR).
URL:https://www.medilinkmidlands.com/event/webinar-the-eu-mdr-deadline-extension-where-are-we-now/
ATTACH;FMTTYPE=image/jpeg:https://www.medilinkmidlands.com/wp-content/uploads/2022/04/Peter-Rose-New-PRQR.jpg
ORGANIZER;CN="Becky Sharpe":MAILTO:events@medilinkmidlands.com
END:VEVENT
END:VCALENDAR